Jirui Zhang - Spring Pharmaceutical Director
Director
Mr. Zhang Jirui is Director of the Company. Mr. Zhang brings over twenty years of technical training to Shandong Spring Pharmaceutical, where he was employed as Director since January 2006. During 2005, Mr. Zhang was the Manager of the International Market Department for Shandong YCT Bioengineering Co., Ltd., which manufactures a wide variety of food supplements and is currently the exclusive supplier for Shandong Spring Pharmaceutical. During the 22 years prior to joining Shandong YCT, Mr. Zhang was employed as an Instructor in the Shandong Chemical Engineering Vocational School. since 2010.
| Age | 59 |
| Tenure | 14 years |
| Phone | 86 53 7426 8278 |
| Web | http://www.yctgroup.com |
Spring Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 12.27 % which means that it generated a profit of $12.27 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 14.93 %, meaning that it created $14.93 on every $100 dollars invested by stockholders. Spring Pharmaceutical's management efficiency ratios could be used to measure how well Spring Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Charles Trimble | KVH Industries | 76 | |
| Mark Ain | KVH Industries | 74 | |
| Brad Burrows | Asure Software | N/A | |
| Barry Allen | BCE Inc | 70 | |
| Adrian Pertierra | Asure Software | 45 | |
| Karen Sheriff | BCE Inc | 63 | |
| Matthew Behrent | Asure Software | 46 | |
| Paul Weiss | BCE Inc | 71 | |
| Sophie Brochu | BCE Inc | 55 | |
| Robert Dexter | BCE Inc | 69 | |
| Randall Waterfield | Asure Software | 43 | |
| Robert Brown | BCE Inc | 74 | |
| Ronald Brenneman | BCE Inc | 68 | |
| Bruce Ryan | KVH Industries | 73 | |
| Robert Heyningen | KVH Industries | 58 | |
| Charles Lathrop | Asure Software | 61 | |
| Daniel Gill | Asure Software | 53 | |
| Robert Simmonds | BCE Inc | 67 | |
| Ian Greenberg | BCE Inc | 77 | |
| Sheila Murray | BCE Inc | 65 | |
| Jennifer Tory | BCE Inc | 65 | |
Management Performance
| Return On Equity | 14.93 | |||
| Return On Asset | 12.27 |
Spring Pharmaceutical Leadership Team
Elected by the shareholders, the Spring Pharmaceutical's board of directors comprises two types of representatives: Spring Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Spring. The board's role is to monitor Spring Pharmaceutical's management team and ensure that shareholders' interests are well served. Spring Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Spring Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zecheng Shao, VP | ||
| Qiang Zhang, Chief Admin. Officer | ||
| Chuanming Li, CFO | ||
| Tinghe Yan, Chairman and CEO | ||
| Dong Li, Director | ||
| Wengao Zhang, Independent Director | ||
| Hanwei Zhou, General Manager of Shandong Spring Pharmaceutical | ||
| Xuzhong Ding, Chief Marketing Officer | ||
| Robert Fanella, Independent Director | ||
| John Wallace, Independent Director | ||
| Sun Maogang, General Manager of Shandong Spring Pharmaceutical | ||
| Jirui Zhang, Director |
Spring Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Spring Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 14.93 | |||
| Return On Asset | 12.27 | |||
| Profit Margin | 20.41 % | |||
| Operating Margin | 28.11 % | |||
| Current Valuation | (31.44 M) | |||
| Shares Outstanding | 29.84 M | |||
| Shares Owned By Insiders | 38.19 % | |||
| Price To Earning | 0.09 X | |||
| Price To Book | 0.01 X | |||
| Price To Sales | 0.02 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Spring Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Spring Pharmaceutical's short interest history, or implied volatility extrapolated from Spring Pharmaceutical options trading.
Pair Trading with Spring Pharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Spring Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spring Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to AutoNation could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AutoNation when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AutoNation - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AutoNation to buy it.
The correlation of AutoNation is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AutoNation moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AutoNation moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AutoNation can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Spring Pink Sheet
If you are still planning to invest in Spring Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spring Pharmaceutical's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |